search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
SC O TLAND


collaboration between industry, universities, NHS, and government, enabling companies to accelerate the creation, testing, and development of products. Centres of excellence and innovation, connected to the National Healthcare Service (NHS), ensures that Scotland offers a perfect test bed environment with access to patients and medical professionals. These centres include:


n The world leading Medical Devices Manufacture Centre (MDMC)


n Strathclyde Institute of Medical Devices n The Institute for Medical Science and Technology (IMSaT)


n The Digital Health and Care Innovation Centre. n The Data Lab n The Innovation Centre for sensing, imaging, and Internet of Things technologies (CENSIS).


n the Industrial Centre for Artificial Intelligence Research (iCaird)


Case Study - EnMovi MedTech firm, EnMovi, selected Glasgow as the location to advance its development of innovative orthopaedic sensors and data analytics after receiving a £2.5m research and development (R&D) grant from Scottish Enterprise. The company is now part of Stryker, a US multinational and one of the world’s leading medical technology companies. The company focuses on developing data analytics, machine learning and mobile applications to support its wearable orthopaedic sensor devices, having established an £8m R&D base in Glasgow. The University of Strathclyde, which has a long-


standing relationship with the company, worked in partnership with Scottish Enterprise to bring the new company to Scotland. Scottish Enterprise is part of this collaborative


ecosystem, working with the Life Sciences Sector Industry Leadership Group (ILG) and Scottish Government to develop and support the implementation of the life sciences sector strategy. We do this by aligning our support with the key


DUSSELDORF 2022


priority areas identified in the ILG’s Scottish Life Sciences Covid-19 Strategic Response Plan: n Digital and data n Skills n Infrastructure


Two of Scottish Enterprise’s high-impact National Programmes directly align with the above key priority areas: n Our Health for Wealth National Programme aims to address current challenges in terms of sustainability and outcome improvement in health and care by building a world leading health and care innovation ecosystem and fully exploiting the potential of digital technologies and data to transform health and care


n The Future Healthcare Manufacturing Programme is using expertise in Scotland to help the industry develop its manufacturing capacity through key mobile investment projects and the existing R&D pipeline, building upon access to skills, existing assets, expertise, and relationships across the industry


Scottish Development International (SDI) is Scotland’s trade and investment agency and aims to make it quick and easy for businesses to settle in Scotland, helping firms identify premises, academic partners and investment opportunities, recruit staff and access funding to upskill staff, develop new products and services and access growth capital. According to the EY Attractiveness Survey 2022 published in May, Scotland was once again judged to be the most attractive location in the UK for Foreign Direct Investment (FDI) outside of London. If you think your company can benefit from all


Scotland has to offer, then we would love to hear from you.


www.sdi.co.uk investment@scotent.co.uk Tel: +44 300 013 2734


UKHEALT HCARE P A VILIO N. COM 11


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52